The Collection and Application of Autologous Amniotic Fluid At Cesarean Delivery Closure. (NCT04359472) | Clinical Trial Compass
CompletedNot Applicable
The Collection and Application of Autologous Amniotic Fluid At Cesarean Delivery Closure.
United States20 participantsStarted 2020-10-01
Plain-language summary
The purpose of this study is to determine the feasibility of collecting amniotic fluid at delivery that will be immediately processed and then applied as a spray to the various layers of cesarean wound closure.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Pregnant female age great than 18 years
✓. Singleton gestation
✓. Plan for cesarean delivery
✓. Planned gestational age of at least weeks at the time of delivery
✓. English speaking
✓. Able to provide own informed consent
✓. Intention of being available for entire study period and complete all relevant study procedures, including follow-up study visits and phone calls
Exclusion criteria
✕. Diabetes requiring therapy (type I or type II diabetes, gestational diabetes on medical therapy)
✕. BMI greater than or equal to 40 kg/m2 at the time of enrollment
✕. Placenta previa or placenta accreta
✕. Prior bowel or urologic surgery (except un-ruptured appendectomy or uncomplicated cholecystectomy)
✕. Multiple gestation
✕. Previous history of postpartum hemorrhage requiring medical or surgical treatment
✕. Known or suspected impairment of immunologic function including infection with HIV, hepatitis B or C
What they're measuring
1
Collection and reapplication of autologous amniotic fluid